Protéines de liaison au TGF-bêta latent : Questions médicales fréquentes
Nom anglais: Latent TGF-beta Binding Proteins
Descriptor UI:D053779
Tree Number:D12.776.860.300.688
Termes MeSH sélectionnés :
Conversion Disorder
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines de liaison au TGF-bêta latent : Questions médicales les plus fréquentes",
"headline": "Protéines de liaison au TGF-bêta latent : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines de liaison au TGF-bêta latent : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-18",
"dateModified": "2025-04-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines de liaison au TGF-bêta latent"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de la matrice extracellulaire",
"url": "https://questionsmedicales.fr/mesh/D016326",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de la matrice extracellulaire",
"code": {
"@type": "MedicalCode",
"code": "D016326",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.860.300"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Protéines de liaison au TGF-bêta latent",
"alternateName": "Latent TGF-beta Binding Proteins",
"code": {
"@type": "MedicalCode",
"code": "D053779",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Nalani Sachan",
"url": "https://questionsmedicales.fr/author/Nalani%20Sachan",
"affiliation": {
"@type": "Organization",
"name": "Department of Cell Biology, NYU Grossman School of Medicine, New York, New York, USA."
}
},
{
"@type": "Person",
"name": "Hui Liu",
"url": "https://questionsmedicales.fr/author/Hui%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Department of Experimental Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, 710038, Shanxi, China."
}
},
{
"@type": "Person",
"name": "Daniel Rifkin",
"url": "https://questionsmedicales.fr/author/Daniel%20Rifkin",
"affiliation": {
"@type": "Organization",
"name": "Department of Cell Biology, NYU Grossman School of Medicine, New York, New York, USA."
}
},
{
"@type": "Person",
"name": "Karan Singh",
"url": "https://questionsmedicales.fr/author/Karan%20Singh",
"affiliation": {
"@type": "Organization",
"name": "Department of Cell Biology, NYU Grossman School of Medicine, New York, New York, USA."
}
},
{
"@type": "Person",
"name": "Hong-Lian Wang",
"url": "https://questionsmedicales.fr/author/Hong-Lian%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Research Center for Integrative Medicine, The Affiliated Traditional Medicine Hospital of Southwest Medical University, Luzhou 646000, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Functional Neurological Disorder in Pediatrics: Diagnostic Considerations.",
"datePublished": "2024-11-01",
"url": "https://questionsmedicales.fr/article/39467190",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Physical Rehabilitation of Motor Functional Neurological Disorders: A Narrative Review.",
"datePublished": "2023-05-11",
"url": "https://questionsmedicales.fr/article/37239521",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20105793"
}
},
{
"@type": "ScholarlyArticle",
"name": "Why functional neurological disorder is not feigning or malingering.",
"datePublished": "2023-02-16",
"url": "https://questionsmedicales.fr/article/36797425",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41582-022-00765-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Overall comorbidities in functional neurological disorder: A narrative review.",
"datePublished": "2023-07-04",
"url": "https://questionsmedicales.fr/article/37414721",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.encep.2023.06.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Validated care programs for patients with functional neurological disorders].",
"datePublished": "2023-07-01",
"url": "https://questionsmedicales.fr/article/37400332",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.encep.2023.06.005"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Scléroprotéines",
"item": "https://questionsmedicales.fr/mesh/D012596"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines de la matrice extracellulaire",
"item": "https://questionsmedicales.fr/mesh/D016326"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines de liaison au TGF-bêta latent",
"item": "https://questionsmedicales.fr/mesh/D053779"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines de liaison au TGF-bêta latent - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines de liaison au TGF-bêta latent",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines de liaison au TGF-bêta latent",
"description": "Comment diagnostiquer une anomalie des protéines de liaison au TGF-bêta ?\nQuels tests sont utilisés pour évaluer le TGF-bêta ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes peuvent indiquer un problème avec le TGF-bêta ?\nY a-t-il des marqueurs spécifiques pour ces protéines ?",
"url": "https://questionsmedicales.fr/mesh/D053779?mesh_terms=Conversion+Disorder&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines de liaison au TGF-bêta latent",
"description": "Quels symptômes sont associés à une dysfonction du TGF-bêta ?\nLa douleur est-elle un symptôme courant ?\nPeut-on observer des anomalies cutanées ?\nLes troubles respiratoires sont-ils liés au TGF-bêta ?\nY a-t-il des signes d'inflammation systémique ?",
"url": "https://questionsmedicales.fr/mesh/D053779?mesh_terms=Conversion+Disorder&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines de liaison au TGF-bêta latent",
"description": "Comment prévenir les troubles liés au TGF-bêta ?\nY a-t-il des mesures spécifiques à prendre ?\nLes vaccinations sont-elles importantes ?\nL'éducation des patients est-elle cruciale ?\nLe suivi médical régulier est-il recommandé ?",
"url": "https://questionsmedicales.fr/mesh/D053779?mesh_terms=Conversion+Disorder&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines de liaison au TGF-bêta latent",
"description": "Quels traitements sont disponibles pour les troubles liés au TGF-bêta ?\nLa thérapie génique est-elle une option ?\nLes corticostéroïdes sont-ils utilisés ?\nY a-t-il des traitements expérimentaux ?\nLes changements de mode de vie peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D053779?mesh_terms=Conversion+Disorder&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines de liaison au TGF-bêta latent",
"description": "Quelles complications peuvent survenir ?\nLes complications cardiovasculaires sont-elles possibles ?\nY a-t-il un risque accru de cancer ?\nLes troubles neurologiques peuvent-ils être liés ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D053779?mesh_terms=Conversion+Disorder&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines de liaison au TGF-bêta latent",
"description": "Quels sont les principaux facteurs de risque ?\nLe vieillissement est-il un facteur de risque ?\nL'obésité influence-t-elle le risque ?\nLe stress a-t-il un impact ?\nLes infections peuvent-elles être un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D053779?mesh_terms=Conversion+Disorder&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des protéines de liaison au TGF-bêta ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins et des analyses génétiques pour détecter des mutations."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer le TGF-bêta ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dosages immunologiques et des tests ELISA sont couramment utilisés pour mesurer le TGF-bêta."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles nécessaires pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des biopsies peuvent être effectuées pour évaluer les tissus affectés et la présence de TGF-bêta."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec le TGF-bêta ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'inflammation chronique ou des troubles de cicatrisation peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs spécifiques pour ces protéines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des marqueurs comme le TGF-bêta actif peuvent être utilisés pour évaluer leur fonction."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à une dysfonction du TGF-bêta ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles immunitaires, des fibroses et des anomalies de cicatrisation."
}
},
{
"@type": "Question",
"name": "La douleur est-elle un symptôme courant ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs peuvent survenir en raison d'inflammation ou de fibrose tissulaire."
}
},
{
"@type": "Question",
"name": "Peut-on observer des anomalies cutanées ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies cutanées comme des cicatrices hypertrophiques peuvent se produire."
}
},
{
"@type": "Question",
"name": "Les troubles respiratoires sont-ils liés au TGF-bêta ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles respiratoires peuvent survenir en raison de fibrose pulmonaire associée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes d'inflammation systémique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des signes comme la fièvre et la fatigue peuvent indiquer une inflammation systémique."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés au TGF-bêta ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par un mode de vie sain et la gestion des maladies inflammatoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures spécifiques à prendre ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabac et l'alcool peut réduire le risque de complications liées au TGF-bêta."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent aider à prévenir les infections qui exacerbent les troubles."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle cruciale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les patients sur les symptômes et les facteurs de risque est essentiel."
}
},
{
"@type": "Question",
"name": "Le suivi médical régulier est-il recommandé ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical régulier permet de détecter précocement les anomalies."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles liés au TGF-bêta ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments anti-inflammatoires et des thérapies ciblées."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique est explorée pour corriger des anomalies génétiques liées au TGF-bêta."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils utilisés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les corticostéroïdes peuvent être prescrits pour réduire l'inflammation associée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements expérimentaux, comme les inhibiteurs de TGF-bêta, sont en cours d'évaluation."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie peuvent-ils aider ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements comme une alimentation saine et l'exercice peuvent améliorer les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des fibroses, des troubles respiratoires et des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les complications cardiovasculaires sont-elles possibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications cardiovasculaires peuvent survenir en raison d'une inflammation chronique."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de cancer ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des études suggèrent un lien entre TGF-bêta et certains types de cancer."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques peuvent-ils être liés ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques peuvent être associés à des déséquilibres du TGF-bêta."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite une approche multidisciplinaire et un suivi régulier."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et l'exposition à des toxines."
}
},
{
"@type": "Question",
"name": "Le vieillissement est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut augmenter le risque de dysfonction des protéines de liaison au TGF-bêta."
}
},
{
"@type": "Question",
"name": "L'obésité influence-t-elle le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité est associée à une inflammation chronique, augmentant le risque de troubles."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut exacerber les troubles liés au TGF-bêta."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent déclencher des réponses inflammatoires affectant le TGF-bêta."
}
}
]
}
]
}
Functional neurological disorder (FND) is a common diagnosis of varied neuropsychiatric symptoms presenting to pediatric healthcare settings, including primary, urgent and subspecialty care. A key dia...
Functional Neurological Disorders (FNDs) are one of the most common and disabling neurological disorders, affecting approximately 10-30% of patients in neurology clinics. FNDs manifest as a range of m...
Functional neurological disorder (FND) is one of the commonest reasons that people seek help from a neurologist and is for many people a lifelong cause of disability and impaired quality of life. Alth...
The importance to assess and include the frequent comorbidities in the personalised care management plan of patients with functional neurological disorders (FND) has arisen through the years. FND pati...
The literature was searched for on Medline and PubMed. The search was narrowed to articles between 2000 and 2022....
Fatigue is the most common symptom reported in relation to FND (from 47 to 93%), followed by cognitive symptoms (from 80 to 85%). Psychiatric disorders are reported in 40 to 100% FND patients, dependi...
Put together, this narrative review highlights the high burden of FND patients, not only due to somatosensory alterations but also by considering the frequent comorbidities reported. Thus, such comorb...
Functional neurological disorder (FND) is a common cause of persistent and disabling neurological symptoms. Diagnostic delay may lead to no treatment, inappropriate treatment or even iatrogenic sympto...
Although functional neurological movement disorders (FMD) are characterized by motor symptoms, sensory processing has also been shown to be disturbed. However, how the integration of perception and mo...
The aim was to investigate perception-action integration processes on a behavioral and neurophysiological level in patients with FMD....
A total of 21 patients and 21 controls were investigated with a TEC-related task, including concomitant electroencephalogram (EEG) recording. We focused on EEG correlates established to reflect percep...
Behaviorally, patients revealed stronger binding between perception and action, as evidenced by difficulties in reconfiguring previously established stimulus-response associations. Such hyperbinding w...
Our study shows that FMD is characterized by altered integration of sensory information with motor processes. Relations between clinical severity and both behavioral performance and neurophysiological...
Functional neurologic disorder (FND) represents genuine involuntary neurologic symptoms and signs including seizures, weakness, and sensory disturbance, which have characteristic clinical features, an...
We searched electronic databases (PubMed, PsycInfo, MEDLINE, EMBASE, and the National Health Service Economic Evaluations Database of the University of York) for original, primary research publication...
The search resulted in a total of 3,244 studies. Sixteen studies were included after screening and exclusion of duplicates. These included the following: cost-of-illness (COI) studies that were conduc...
FND is associated with a significant use of health care resources, resulting in economic costs to both the patient and the taxpayer and intangible losses. Interventions, including accurate diagnosis, ...
Motor symptoms in functional movement disorders (FMDs) are experienced as involuntary but share characteristics of voluntary action. Clinical and experimental evidence indicate alterations in monitori...
The objective of this study was to test the prediction that FMDs are associated with a reduced ability to make accurate (metacognitive) judgments about self-performed movements....
We compared 24 patients with FMD (including functional gait disturbance, functional tremor, and functional tics) with 24 age- and sex-matched healthy control subjects in a novel visuomotor-metacogniti...
Patients and control subjects showed comparable motor performance, response accuracy, and use of the confidence scale. However, visuomotor sensitivity in the trajectory judgment was reduced in patient...
Patients with FMD exhibited deficits both when making visuomotor decisions about their own movements and in the metacognitive evaluation of these decisions. Reduced metacognitive insight into voluntar...
Functional neurological disorders have witnessed intense research activity in the fields of structural and functional neuroimaging for more than twenty years. Thus, we propose a synthesis of recent re...
We carried out a narrative review of international publications dealing with neuroimaging and biology of functional neurological disorders, from 1997 to 2023....
Several brain networks underlie functional neurological symptoms. These networks play a role in the management of cognitive resources, in attentional control, emotion regulation, in agency and in the ...
A better knowledge of the biopsychosocial determinants of brain network dysfunctions is necessary. Understanding them would help developing targeted treatments, but is also critical for patients care....
Until the outbreak reported during the COVID-19 pandemic, functional tics were considered to be a relatively rare clinical phenotype, as opposed to other functional movement disorders such as function...
Data from 110 patients were collected at the same neuropsychiatry centre: 66 consecutive patients who developed functional tics without other functional motor symptoms or neurodevelopmental tics and 4...
Both groups were characterized by female sex preponderance (70%-80%) and (sub)acute onset of functional symptoms (~80%). However, patients with functional tics had a significantly earlier age at onset...
Patients who developed functional tics during the pandemic represent a phenotypic variant of the wider group of patients with functional movement disorders, associated with younger age at onset and in...